DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dinoprostone Vaginal (Dinoprostone Vaginal Insert) - Drug Interactions, Contraindications, Overdosage, etc

 
 



DRUG INTERACTIONS

DINOPROSTONE VAGINAL drug label information in our database does not contain a dedicated section on drug interactions. Please check subsections of WARNINGS AND PRECAUTIONS as well as other sources.

OVERDOSAGE

Cervidil is used as a single dosage in a single application. Overdosage is usually manifested by uterine hyperstimulation which may be accompanied by fetal distress and is responsive to removal of the insert. Other treatment must be symptomatic since, to date, clinical experience with prostaglandin antagonists is insufficient.

The use of beta-adrenergic agents should be considered in the event of undesirable increased uterine activity.

CONTRAINDICATIONS

Cervidil is contraindicated in:

  • Patients with known hypersensitivity to prostaglandins.
  • Patients in whom there is clinical suspicion or definite evidence of fetal distress where delivery is not imminent.
  • Patients with unexplained vaginal bleeding during this pregnancy.
  • Patients in whom there is evidence or strong suspicion of marked cephalopelvic disproportion.
  • Patients in whom oxytocic drugs are contraindicated or when prolonged contraction of the uterus may be detrimental to fetal safety or uterine integrity, such as previous cesarean section or major uterine surgery ( see PRECAUTIONS and ADVERSE REACTIONS).
  • Patients already receiving intravenous oxytocic drugs.
  • Multipara with 6 or more previous term pregnancies.

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017